Market Place
Sourcing Support
Amneal’s Generics Deflazacort Receives Approval in US
12 Dec 2025 //
FDA
Amneal Wins FDA Approval for Epinephrine Injection Vials
09 Dec 2025 //
GLOBENEWSWIRE
Amneal’s Generics Epinephrine Receives Approval in US
08 Dec 2025 //
FDA
Amneal Reports Positive Interim Phase 4 ELEVATE-PD Results
05 Dec 2025 //
GLOBENEWSWIRE
Amneal To Participate In Upcoming Investor Conferences
02 Dec 2025 //
GLOBENEWSWIRE
Amneal Gets FDA Nod For Albuterol Sulfate Inhaler
02 Dec 2025 //
GLOBENEWSWIRE
Amneal’s Generics Albuterol Sulfate Receives Approval in US
01 Dec 2025 //
FDA
Amneal Gets FDA Nod For Cyclosporine Ophthalmic Emulsion 0.05%
01 Dec 2025 //
GLOBENEWSWIRE
Amneal’s Generics Iohexol Receives Approval in US
13 Nov 2025 //
FDA
Amneal Receives U.S. FDA Approval For Iohexol Injection
13 Nov 2025 //
GLOBENEWSWIRE
Amneal’s Generics Phytonadione Receives Approval in US
04 Nov 2025 //
FDA
Amneal Reports Third Quarter 2025 Financial Results
30 Oct 2025 //
GLOBENEWSWIRE
Amneal’s Generics Neomycin Receives Approval in US
29 Oct 2025 //
FDA
Amneal Gets FDA Tentative Approval For Beclomethasone Aerosol
29 Oct 2025 //
GLOBENEWSWIRE
Amneal Launches Brekiya – the First and Only DHE Autoinjector
27 Oct 2025 //
GLOBENEWSWIRE
Amneal’s Generics Epinephrine Receives Approval in US
14 Oct 2025 //
FDA
Amneal Pharms’s Generics Isotretinoin Receives Approval in US
07 Oct 2025 //
FDA
Amneal’s Generics Labetalol Hydrochloride Receives Approval in US
02 Oct 2025 //
FDA
Amneal To Report Third Quarter 2025 Results On October 30, 2025
30 Sep 2025 //
GLOBENEWSWIRE
Amneal Submits Biosimilar BLA For Xolair (omalizumab)
26 Sep 2025 //
GLOBENEWSWIRE
Amneal Pharmaceuticals is on Health Canada Inspection List
25 Sep 2025 //
HEALTH CANADA
Amneal Gets FDA Nod For Bimatoprost Ophthalmic Solution 0.01%
23 Sep 2025 //
GLOBENEWSWIRE
Amneal Receives U.S. FDA Approval of Sodium Oxybate Oral Solution
11 Sep 2025 //
GLOBENEWSWIRE
Amneal`s Generics Sodium Oxybate Receives Approval in US
10 Sep 2025 //
FDA
Enforcement Report - Week of September 10, 2025
10 Sep 2025 //
FDA
Amneal Gets Approval for Risperidone Extended-Release Injection
04 Sep 2025 //
GLOBENEWSWIRE
Amneal`s Generics Risperidone Receives Approval in US
02 Sep 2025 //
FDA
Amneal Pharmaceuticals Recieves Warning Letter
02 Sep 2025 //
FDA
Amneal Reports Second Quarter 2025 Financial Results
05 Aug 2025 //
GLOBENEWSWIRE
Amneal Reveals Preliminary Q2 2025 Financial Results
21 Jul 2025 //
GLOBENEWSWIRE
Amneal Proposes Refinancing of Credit Agreement
21 Jul 2025 //
GLOBENEWSWIRE
Amneal`s Q2 2025 Results to be Reported on August 5
09 Jul 2025 //
GLOBENEWSWIRE
Amneal, Kashiv Report Positive Data for Xolair Biosimilar
25 Jun 2025 //
GLOBENEWSWIRE
Enforcement Report - Week of June 18, 2025
18 Jun 2025 //
FDA
Amneal gets FDA approval for Prednisolone Acetate Ophthalmics
13 Jun 2025 //
GLOBENEWSWIRE
Amneal Nationwide Recalls Sulfamethoxazole Trimethoprim Tablets
04 Jun 2025 //
FDA
Amneal to Participate at Upcoming Investor Conferences in June
29 May 2025 //
GLOBENEWSWIRE
Girard Sharp and Motley Rice Announce Proposed Settlement
27 May 2025 //
PR NEWSWIRE
FDA approves Amneal`s self-administered migraine treatment
16 May 2025 //
REUTERS
Enforcement Report - Week of May 14, 2025
14 May 2025 //
FDA
Amneal and Apiject to Expand Sterile and BFS Capabilities in US
08 May 2025 //
GLOBENEWSWIRE
Amneal Reports First Quarter 2025 Financial Results
02 May 2025 //
BUSINESSWIRE
Amneal recalls 2 lots of hospital med over contamination fears
21 Apr 2025 //
FIERCE PHARMA
Amneal Issues a Nationwide Recall of Ropivacaine HCl
18 Apr 2025 //
FDA
Amneal Donates $1.5 Million for Parkinson`s Awareness Month
11 Apr 2025 //
BUSINESSWIRE
Amneal to Report First Quarter 2025 Results on May 2, 2025
08 Apr 2025 //
BUSINESSWIRE
Amneal reveals Phase 3 data on CREXONT® in Parkinson’s Disease
07 Apr 2025 //
BUSINESSWIRE
Amneal expands Crexont® coverage for U.S. Parkinson`s patients
03 Apr 2025 //
BUSINESSWIRE
Amneal Launches Boruzu for Multiple Myeloma & Lymphoma
01 Apr 2025 //
BUSINESSWIRE
Amneal to Participate at Upcoming Investor Conference
10 Mar 2025 //
BUSINESSWIRE
FDA Accepts Amneal’s BLA for Two Denosumab Biosimilars
03 Mar 2025 //
BUSINESSWIRE
Amneal Reports Fourth Quarter and Full Year 2024 Financial Results
28 Feb 2025 //
BUSINESSWIRE
Enforcement Report - Week of February 26, 2025
26 Feb 2025 //
FDA
Amneal Launches Mesalamine, Gets FDA Nod For Lenalidomide
19 Feb 2025 //
BUSINESSWIRE
Amneal to Report Q4 & Full Year 2024 Results on Feb 28
29 Jan 2025 //
BUSINESSWIRE
Amneal Gets FDA Nod For Memantine/Donepezil & Everolimus
23 Jan 2025 //
BUSINESSWIRE
Enforcement Report - Week of January 22, 2025
22 Jan 2025 //
FDA
Amneal`s Generics Rifaximin Receives Tentative Approval in US
16 Jan 2025 //
FDA
Enforcement Report - Week of January 15, 2025
15 Jan 2025 //
FDA
Amneal Pharma`s Generics Everolimus Receives Approval in US
10 Jan 2025 //
FDA
